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Summary Recent immunocytochemical and biochemical studies have shown the intracellular uptake of
alpha-foetoprotein (AFP) by most neural crest and neural tube derivatives of developing mammals and birds.
The neural crest origin of neuroblastomas has been known for a long time. While many mouse
neuroblastoma cell lines can express several neuronal properties, other lines lack specialized neural functions
and may re-express embryonal or foetal antigens, suggesting some reversion towards an earlier stage of
differentiation. We have therefore tested the C-1300 Jackson mouse neuroblastoma cell line for its ability to
incorporate AFP. The results obtained confirm the significant internalization of protein by these cells, both in
vitro and in vivo. External photoscans of mice bearing tumours after injection with [131I]-AFP have proven
the usefulness of the protein as a radiotracer for neuroblastoma localization.
Proliferating cell lines of neuroblastoma express
several neuronal characteristics such as process
formation (Schubert et al., 1969), neurotransmitter
synthesis (Biedler et al., 1978; Pons et al., 1982),
high acetylcholinesterase and electrical activities.
They lack, however, the ability to synapse between
themselves (Zagon et al., 1978) and have a less
complex ganglioside pattern than is found for
neurons (Stoolmiller, 1973). A number of cell
surface antigens of neuroblastomas are also
expressed by cells in mature brain (Casper et al.,
1977). On the other hand, foetal onconeural
antigens have been described which are expressed
by both neuroblastoma and foetal neural cells
(Kennet & Gilbert, 1979).
Recent immunocytochemical work in our
laboratory has shown the intracellular presence of
alpha-foetoprotein (AFP) and also of serum albumin
(SA) in most neural crest and neural tube
derivatives of developing mammals (Trojan & Uriel,
1980; Uriel et al., 1982) and birds (Moro & Uriel,
1981) during a transitory period of their maturation
pathways. Several in vitro (Uriel et al., 1981) and in
vivo (Villacampa et al., 1983; Pineiro et al., 1982;
Moro et al., 1984) studies support the conclusion
that the presence of AFP, and perhaps of SA,
results from protein uptake as opposed to eventual
in situ synthesis (Ali et al., 1983). The ability to
incorporate AFP, common to many tissues during
ontogenesis may reappear in neoplastic cells (Uriel
et al., 1983; 1984a). We have tested the C-1300
neuroblastoma cell line for its potentiality to
internalize AFP and SA, both in vitro and in vivo.
Ovalbumin (OA), a low molecular weight protein
was used as a negative control.
Material and methods
Cells
The C-1300 uncloned cell line was routinely
maintained in Eagle's medium (MEM enriched with
non essential amino acids; Seromed, West
Germany) containg 10% foetal calf serum (FCS)
inactivated at 56°C for 30min, penicillin and
streptomycin (100U/100upgml-1). The cells were
incubated at 37°C in a humidified atmosphere
of 5% CO2 in air. The average population doubling
time was 24h. Cell viability was determined by
trypan blue exclusion. Cultures were trypsinized
before attaining confluency and replated in plastic
tissue culture dishes (35 mm; Falcon) at a density of
7 x 104 cells per dish in 1.5ml of growth medium
and cultured for 48h.
Protein preparations
Mouse AFP was isolated from a PBS-homogenate
of 17 day old mouse foetuses as previously
described (Hassoux et al., 1977). Rat serum albumin
was from Nordic (the Netherlands) and ovalbumin
from Sigma (USA).
Flouresceinated conjugates
Mouse AFP, rat SA and OA were conjugated to
fluorescein isothiocyanate (FITC) following the
technique described previously (Uriel et al., 1983). A
fluorescein-lysine conjugate (FITC-lys) was prepared
by coupling 1ml of 0.2ML-lysine with 0.4mg of
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FITC and used as a control. Nuclei were
counterstained with p-phenylenediamine as
described by Oriol et al. (1983).
1251 or 131I labelling
Proteins (20,jg) were labelled with 1mCi of either
1251 or 13'I by the chloramine T method (Hunter,
1978). Specific activities ranged from 2 to
15jiCijig- 1 of protein.
AFP incubation ofcells
After incubation for 48h, as indicated above, the
medium was removed and the plates incubated for
1 h in serum-free medium to deplete cells of
endogenous bovine AFP. Then, 1ml per plate of
fresh medium containing 100jig of fluorescein
conjugates of mouse AFP (FITC-AFP), rat serum
albumin (FITC-SA) or ovalbumin (FITC-OA) was
added. The cells were incubated in this medium for
4h at 37°C. They were washed 3 times with sterile
PBS before being fixed in acid ethanol (ethanol 70%
in PBS, acetic acid 1%) at room temperature,
mounted in 30% glycerol phosphate buffer
0.05 M pH 7.6 and examined with a microscope
equiped with fluorescein optics and epi-illumination.
Alternatively, after acid-alcohol fixation, cultures
were processed for immunocytochemical labelling.
Control dishes containing no FITC-proteins or
FITC-lysine were treated in parallel.
Immunocytochemistry
Anti-mouse AFP was produced in rabbits as
previously described (Hassoux et al., 1977). Rabbit
antisera to rat SA and to ovalbumin (OA) were
obtained from Nordic (the Netherlands). Vectastain
ABC kit was purchased from Vector Lab., USA. No
cross reactivity was found by immunodiffusion
methods between anti-mouse AFP or anti-rat SA
antibodies and calf serum proteins.
Experimental and control dishes were treated
with either rabbit anti-AFP, anti-SA or anti-OA
(1/200v/v) for 45 min at room temperature and then
processed by the ABC immunoperoxidase technique
according to Hsu et al. (1981).
Tumours
To induce tumour formation, male A/J mice
weighting 20 to 25g were inoculated s.c. in the
scapular region with 0.5 ml of a suspension
containing 106 viable tumour cells. All animals were
examined daily for the appearance of palpable
tumours. Mice injected with neuroblastoma cells
developed tumours within 15-20 days after
injection. When the tumours measured - 9 mm in
diameter, -3jig each of [125I]-AFP, [125I]-SA or
[1251]-OA were injected i.p. Three to four days after
injection, mice were anaesthetized with ether and
perfused at 37°C through the left ventricule with
50-60ml of 10mM K-phosphate, 150mMNaCl and
1 mM EDTA buffer, pH 7.4. Perfusion was carried
out with a peristaltic pump after section of the
jugular vein before perfusion was started. Tumour
and aliquots of other normal solid tissues (spleen,
lung, brain, heart and liver) were rapidly dissected,
washed in PBS, weighed and measured for radio-
activity in a y-counter. Fragments of all organs
were fixed for 3 days in cold ethanol/acetic acid
(98/2;v/v) or Bouin's fixative, embedded in paraffin
and sectioned at 3-4jm for a haematoxylin-eosin
observation or autoradiography. Blood, liver and
tumour samples were homogenized with PBS (1/2;
w/v) and precipitated with trichloracetic acid (TCA,
10% final concentration). Concentration values in
nCig-1 of tissue were estimated, and tumour to
liver ratios were calculated by dividing nCig-
values in the tumour by those in the liver. For a
comparison of [125I]-AFP, [125]I)-SA and [125I]-OA
distribution in mice specificity indices were obtained
by dividing individual nCig-1 values for AFP or
SA by those obtained for OA.
Scintigraphy
In order to test the possibility of tumour
localization of radiolabelled AFP by external
photoscanning, mice were injected i.p. with [1311]_
AFP (20-40jCi, i.e. 0.5-l.Ojg AFP) or with
[13'I]-OA (40,pCi; 4jig-OA). Images were obtained
3-6 days after injection with a standard y-camera
linked to a computer with data display. During
photoscanning, mice were anaesthetized with
sodium pentobarbital and immobilized in the prone
position. Counts were calculated at different regions
of interest including total body and tumor.
Results
Morphology
The majority of cells in culture had round or ovoid
bodies of 15-30pm in diameter, with a single
nucleus of 12-20,jm. Variation in number, length,
diameter and arborization of cells was noted. Large
flattened cells with diameters up to 100jim were
also observed; these cells often appeared to be
multinucleated. Tumours consisted of masses of
round cells separated by small quantities of inter-
cellular substance. The rounded nuclei were
centrally located, displayed a thin border of hetero-
chromatin and often contained several prominent
nucleoli. The undifferentiated tumour cell typically
displayed a high nuclear: cytoplasmic ratio. Multi-
nucleated cells were rare.ALPHA-FOETOPROTEIN UPTAKE BY NEUROBLASTOMA 793
Protein uptake
FITC-conjugates of AFP, SA or OA were added as
described above. After a 4h incubation at 37°C,
specific fluorescence for AFP and SA could be
observed in a large number of cells: the fluorescence
appeared to be intracytoplasmic and often extended
into the pseudoneuronal processes (Figure la for
AFP). No positive labelling could be observed for
the FITC conjugated OA. Control cultures
containing the FITC-lysine also appeared negative.
Immunocytochemistry
AFP positive cells revealed with antibodies to AFP
are shown in Figure lb. Here too, the incorporation
appeared to be intracytoplasmic and extended to
cell processes. Although, as indicated above, some
heterogeneity was noticed in cell morphology, AFP
staining was indistinguishably positive in the whole
population. Cell nuclei were systematically AFP-
negative. The same localization was observed in
cells incubated with SA and revealed with anti-SA
antibodies. No significant staining was revealed in
cultures treated with OA. When neither AFP, SA or
OA was added, control cultures appeared totally
negative.
Distribution ofradioactivity
Table I shows the tissue distribution of [1251]-AFP
after injection into tumour bearing animals. Radio-
activity concentration (mean value+s.e.) in the
tumour was the highest among all solid tissues
examined. Tumour-to-liver radioactivity ratios were
clearly positive (mean value 3.8+0.6) and ratios of
tumour AFP content versus brain, spleen, heart and
lung confirmed the significant accumulation of the
protein in the tumour.
The radioactivity recovered in TCA precipitates
from tissue homogenates averaged 72% for liver
samples and respectively 87 and 93% for tumour
and blood.
Table II shows accumulation of [125I]-OA in the
tissues examined-including the tumour, relative to
radio-iodinated AFP and SA. The tumour-to-liver
ratio for OA (0.42+0.09) was very low. This may
have been due to lack of specific OA-uptake by the
tumour and to an accelerated catabolism of OA, a
heterologous protein. The specificity indices
obtained for AFP and SA in these mice confirmed
the efficiency of AFP and SA concentrations in the
tumour as compared to normal solid tissues. The
tumour-to-liver ratios were respectively, 3.8+0.6
and 5+ 1.9 for AFP and SA. In addition, the
average tumour-to-liver ratios for AFP and SA
were 9 to 12 fold higher than for OA.
Autoradiographs
Examination of autoradiographs from tumours and
other normal solid tissue sections confirmed the
selective accumulation of radioiodinated AFP in the
tumour. The localization was mainly cytoplasmic
(Figure 2a, 2b). While quantitative variations could
be observed among all tumour sections observed,
the quantitative tumour-to-liver staining ratio always
appeared positive. Some areas, corresponding to
small local necroses, were not considered.
Scintigraphic imaging ofmice bearing neuroblastomas
Four mice were injected with ['25I]-AFP and one
with [13II]-OA. About fifty thousand total counts
were collected over 10 to 30min. In mice injected
with [13'I]-AFP a selective accumulation of radio-
activity could be detected by external photo-
scanning in areas corresponding to tumour location.
By contrast, no tumour imaging was obtained in
the mouse injected with [13'I]-OA. The image of
one mouse injected with [131I]-AFP is shown in
Figure 3. The localization of the tumour is clearly
seen, though this black and white copy does not
reproduce correctly the nuances observable in the
original colour picture (see legend to Figure 3).
Discussion
The results presented here show that C-1300 neuro-
blastoma cells possess in vitro the ability to
incorporate exogenous AFP, as was previously
described for other neoplastic cell systems (Uriel et
al., 1983, 1984a). After grafting into syngeneic hosts,
the developed tumours retained the property of
AFP uptake, as did the mouse mammary
carcinomas previously studied (Uriel et al., 1984b).
We have taken advantage of this to try to use AFP
as a radiotracer for neuroblastoma localization.
This study shows that rat SA, like AFP, is
internalized by neuroblastoma tumour cells in vitro.
In addition, the average of tumour-to-liver ratios
from animals injected with ['251]-SA was even
greater than that from animals receiving [125I]-
AFP (Table II). This may be related to previous
observations showing that the intracellular presence
of SA in the central nervous system of developing
animals follows the same pattern of cell and tissue
localization as does that of AFP (Mollgard et al.,
1979; Toran-Allerand, 1980; Trojan & Uriel, 1979).
Morphologically, mouse neuroblastoma constitutes
the homologue of neuroepithelial proliferation
observed in differentiating mouse teratocarcinoma794 M. HAJERI-GERMOND et al.
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Figure 1 Neuroblastoma C-1300 cells incubated at 37°C with mouse FITC-AFP (100pgml-1). (a)
Fluorescence micrograph. Green, FITC fluorescence was localized in the cytoplasm. Nuclei were counter-
stained with p-phenylenediamine (see Materials and Methods). (b) Immunocytoperoxidase staining. Nuclei
slightly counterstained with haematoxylin ( x400).
Figure 2 Autoradiographs counterstained with haematoxylin: sections of a neuroblastoma tumour developed
in a mouse injected s.c. with C-1300 cells. The animal was injected with [125I]-AFP (20 Ci) and killed 4 days
after. Sections (3-6um thickness) of the tumour mounted on glass slides and covered with Ilford K5
photographic emulsion were examined after 3 weeks standing at +4°C. (a) Silver grains concentrated in the
cytoplasm of elements arranged in undifferentiated structures (x 100). (b) Intracytoplasmic labelling of a
neuroepithelial, vesicle-like structure constituted by hyperchromatic cells surrounding a cavity ( x 400).
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Table I Distribution of [1251]-AFP 3 to 4 days after injection into tumour bearing animalsa
nCiAFPg-I tissue
Tumour:
Mouse no. Blood Tumour Liver Brain Spleen Lung Heart liver ratio
1 157 32.2 6.6 0.99 20 21 15 4.8
2 67 9.7 4.5 0.35 9.2 6.3 3.8 2.16
3 44 15.2 8.5 1.4 1.77
4 22.9 10.7 6 0.34 1.1 1.78
5 176 80 14.9 22 22 11.7 5.4
6 160 39.6 17.4 0.5 12.7 2.2 2.9 2.3
7 162 57.4 6.5 17 1.72 5.4 8.7
8 151 43.2 8.1 2.1 22 1.7 7.2 5.3
9 156 39.4 14 0.33 15.7 4.5 6.8 2.8
10 106 51.8 10.5 0.25 19 16.6 7.3 5
11 52 21.7 12 11 2.9 6.3 1.8
Mean values 114 36.4 9.7 0.69 16.5 8.7 6.2 3.8
+s.e. +17 +3.3 +1.2 +0.25 +1.5 +2.8 +1.2 +0.6
(N) (TI1) (r 1) (c 1) (7) (9) (9) by 1) (t 1)
'Tumour-to-liver ratios were calculated by dividing nCi values in the tumour by those in the liver.
Table II Comparison of [1251]-AFP, [1251]-SA and
['251]-OA distribution in mice bearing neuroblastomasa
Specificity
nCi proteing1 tissue indicesc
AFP SA
AFP -
Organ (n=11) SA(n=4) OA(n=4) OA OA
Blood 114+ 17 640+237 2.4±0.7 47.5 266
Tumour 36.4+3.3 216+70 1.4+0.2 26 154
Liver 9.7+ 1.2 42+ 19 3.3+0.2 3 12.7
Spleen 16.5+ 1.5 109+50 3±0.4 5.5 36
Heart 6.2+ 1.2 43.6 0.7+0.1 8.8 62
Brain 0.69+0.25 2.27+0.6 0.53±0.1 1.3 4.28
T:L ratiob 3.8+0.6 5+1.9 0.42+0.09 8.6 12
aApproximatively IOpCi per mouse of each [1251]-AFP,
[125I]-SA or [1251]-OA were injected i.p.
bTumour-to-liver ratios were calculated by dividing
individual AFP-SA or OA nCi values in the tumour by
those in the liver.
cSpecificity indices were obtained by dividing individual
nCi values for AFP or SA by those for OA.
Figure 3 External photoscanning of a mouse bearing
a single (large) tumour in the upper left part of the
dorsal region. The mouse was injected with [13II]-AFP
(30.uCi) i.p. 4 days before tumour imaging. The
contour of the mouse has been positioned over the
scan. The image was performed with an Informatck
Simis 3 computer and was not corrected by data
subtraction. The picture presented is a black and white
copy from a negative colour fi'lm. This treatment
changes original colour nuances (i.e., orange back-
ground turns white),
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(Gaillard et al., 1984). At this stage of differen-
tiation, the intensity of staining for both AFP and
SA in mouse teratocarcinoma is similar (Trojan et
al., 1983). No significant uptake could be
demonstrated for OA, a low mol. wt protein (43,000)
as compared to AFP (73,000). In this laboratory we
have recently shown the presence of specific AFP
receptors at the surface of some neoplastic cells in
culture(Villacampaetal., 1984;Naveletal., 1985). Itis
reasonable to advance the hypothesis that similar
receptorsmightbeexpressedbyC-1300neuroblastoma
cells.
The great variability observed in the individual
AFP tumour-to-liver ratios (Table I) could be due,
at least in part, to the degree of differentiation
associated with the presence of heterogeneous cell
populations in single tumours (Bernal et al., 1983).
Previous work with primary cultures of dissociated
foetal brain cells and organotypic cultures of
sensory dorsal root ganglia demonstrated that AFP
uptake is not displayed by undifferentiated cell
precursors, but seems restricted to elements with
phenotypic characteristics of maturing neurons
(Uriel et al., 1981; Hajeri-Germond et al., 1983/84).
Immunocytochemical work has shown that the
intracellular presence of AFP and SA during
development is also associated with a certain degree
of cell and tissue differentiation (Trojan & Uriel,
1982). Neither undifferentiated nor fully differen-
tiated cells incorporate AFP.
As compared to monoclonal or polyclonal
antibodies to tumour antigens, AFP may be used to
advantage in radiotracing experiments, since this
isologous protein is not expected to induce hyper-
sensitivity reactions. On the other hand, and
contrary to SA, the extremely low serum levels of
AFP in adult individuals should minimize effects
due to competition with endogenous protein. This
makes AFP a good candidate for tumour
localization by imaging techniques.
We want to thank Dr B. Mensch and Dr P. Toussaint
from the Hospital Tenon (Service of Radiobiology, Paris,
France), who allowed us to realize the external photoscans.
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